Canada markets open in 1 hour 59 minutes

MedX Health Corp (MDX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1150-0.0050 (-4.17%)
At close: 2:34PM EDT
Full screen
Previous Close0.1200
Bid0.1100 x 0
Ask0.1150 x 0
Day's Range0.1100 - 0.1150
52 Week Range0.1000 - 0.2600
Avg. Volume167,079
Market Cap20.92M
Beta (5Y Monthly)-0.05
PE Ratio (TTM)N/A
EPS (TTM)-0.0230
Earnings DateNov. 29, 2021 - Dec. 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    MedX to Present at Benzinga Healthcare Conference on September 30th

    Mississauga, Ontario--(Newsfile Corp. - September 29, 2021) - MedX Health Corp. (TSXV: MDX) ("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce its participation in the Benzinga Healthcare Small Cap Conference (the "Conference"), taking place virtually on Thursday, September 30th at 4:40 PM ET. MedX President & CEO, Sylvain Desjeans, along with Mike Druhan, President Dermatological Services, will present the Company's vision for scaling access to its unique derm

  • Business Wire

    MedX Health Corp. and Vitamed Biomedical s.r.l. to Pilot Leading-Edge Teledermatology Screening Platform in Italy

    MISSISSAUGA, Ontario, September 27, 2021--MedX Health Corp. ("MedX" or the "Company") (MDX - TSXV) and Vitamed Biomedical s.r.l. ("Vitamed") are pleased to announce a Memorandum of Understanding between the companies to pilot MedX’s leading-edge DermSecure® Screening Platform at select pharmacies and general practitioner (GP) clinics in Italy this October.

  • GlobeNewswire

    Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to to view presentationsNEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences